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Abstract 
The idea that drug use in ‘softer’ forms leads to ‘harder’ drug use lies at 
the heart of the gateway theory, one of the most influential models of 
drug use of the twentieth century.  Although hotly contested, the notion 
of the ‘gateway drug’ continues to rear its head in discussions of drug 
use—most recently in the context of electronic cigarettes.  Based on a 
critical reading of a range of texts, including scholarly literature and 
media reports, we explore the history and gestation of the gateway 
theory, highlighting the ways in which intersections between academic, 
media and popular accounts actively produced the concept.  Arguing 
that the theory has been critical in maintaining the distinction between 
‘soft’ and ‘hard’ drugs, we turn to its distinctive iteration in the context of 
debates about e-cigarettes.  We show that the notion of the ‘gateway’ 
has been transformed from a descriptive to a predictive model, one in 
which nicotine is constituted as simultaneously ‘soft’ and ‘hard’—as both 
relatively innocuous and incontrovertibly harmful.   
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Introduction  
The idea that drug use in ostensibly harmless forms engenders more harmful drug use 
took hold in the twentieth century in tandem with increasing efforts to regulate and 
restrict drugs, reaching its epitome in the ‘gateway theory’ (also known as the ‘gateway 
hypothesis’).  As its name suggests, the assumption at the heart of this concept is that 
certain drugs act as a ‘gateway’ to the usage of other drugs.  This notion is readily 
invoked in discussions of a variety of substances, from cigarettes and alcohol, to 
cannabis and solvents.  It has also featured prominently in debates about newer 
products such as electronic cigarettes (or ‘e-cigarettes’).  However, although a seemingly 
straightforward theory, it is one with a complicated gestation and history.   
 
In this paper we explore the history of this concept, highlighting the intersections 
between academic, media and popular accounts.  We focus on the role of the gateway 
theory in not just describing relationships between forms of drug use but in categorizing 
different drugs and constituting them as harmful in particular ways.  Our interest in the 
gateway theory and its effects on public discourse about drugs has been provoked by 
the debates about e-cigarettes and their relationship to smoking.  As we aim to show in 
the second half of the paper, while the argument that e-cigarette use could lead to young 
people taking up smoking explicitly deploys the gateway theory, it is also quite different 
from earlier claims about ‘soft’ drugs as a stepping stone to ‘hard’ drugs.   
 
Our exploration of the gateway theory and its re-emergence in debates about e-
cigarettes is based on a critical reading of a range of texts, including scholarly literature 
and media accounts.  Academic and policy literature on the gateway theory was found 
through searches of Google Scholar and media accounts were found through a search 
of LexisNexis.  We also conducted Google Scholar searches to explore the literature 
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discussing e-cigarettes in the context of gateway usage, along with broader Google 
searches to examine the ways the term ‘gateway’ is currently being employed in the 
media—both in accounts of e-cigarettes and beyond them.  
 
The analysis that follows is not intended to represent a comprehensive review of the 
literature on this topic, although we have tried to conduct our search of the relevant 
bodies of literature in a reasonably organized and logical fashion (further detail is 
provided in the relevant sections below).  Importantly, our goal is not to prove or 
disprove the veracity of the gateway theory; instead, our approach to this subject matter 
is influenced by material-semiotic approaches which take account of the role of both 
signs and things in the production of reality (e.g. Latour, 2007; Fraser & valentine, 2008; 
Law, 2009).  As Law (2009, p. 142) observes, “If all the world is relational, then so too 
are texts.  They come from somewhere and tell particular stories about particular 
relations”.  It is these stories we aim to explicate in the paper, focusing particularly on the 
ways that the concept has been continuously dismantled, reassembled and 
reappropriated, and its critical role in producing the notion of drug harms.  
 
The origins of the gateway theory 
Any consideration of the origins of the gateway theory must attend to its predecessor, 
the ‘stepping stone theory’, which formed the backdrop against which the notion of the 
‘gateway drug’ emerged.  The origins of the ‘stepping stone’ view of drugs are obscure, 
and sources attribute its roots differently.  According to Sifanek and Kaplan (1995), the 
notion was initially articulated in a pamphlet printed by the U.S. Bureau of Narcotics in 
1965 and asserted that drug users who begin with cannabis increase their risk of 
involvement with LSD, cocaine and heroin.  However, Morral et al. (2002) suggest that 
the concern that marijuana use increases the risk of progressing to other more serious 
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drugs has influenced US drug policy since the 1950s, and Kandel (2002) and Anthony 
(2012) cite research suggesting that such assertions were made from at least the 1930s.  
Thus, it seems that the notion of a ‘stepping stone’ view of drugs drew much of its 
impetus largely from popular wisdom, which would have it that “a joint today means a 
junkie tomorrow” (Louiselle & Whitehead, 1971, p. 347).  
 
The origins of the gateway theory are similarly opaque.  Denise Kandel is typically 
credited with introducing the concept in a 1975 paper titled ‘Stages in adolescent 
involvement in drug use’ published in Science (e.g. van Bilson & Wilke, 1998; Golub & 
Johnson, 2002; Reid et al., 2007; Vanyukov et al., 2012).  In many respects, the paper 
was set up as a rejoinder to the stepping stone theory, as Kandel began by referencing 
the widespread view that marijuana is “the first step in drug use”, suggesting that this 
view was both “arbitrary and inadequately documented” (p. 912).  Based on two 
longitudinal cohort surveys conducted with 6,453 students from 18 New York high 
schools, Kandel argued that adolescent drug use has four distinct stages, with 
adolescents proceeding from beer and wine, to hard liquor and cigarettes, to marijuana, 
to other illicit drugs (see figure 1).  She concluded that if adolescents progress to 
marijuana use (stage 3), this greatly increased their likelihood of using other ‘harder’ illicit 
drugs—from about 2-3% to between 16-26%.  According to Kandel, these stages were 
unaffected by gender, educational background or ethnicity, although she did allow that 
they were “probably culturally determined” (p. 914).   
 
FIGURE 1 ABOUT HERE 
 
Two features of this paper are worth highlighting.  First, in contrast to the assumption of 
marijuana as an inexorable stepping stone to illicit drugs, Kandel made no claims about 
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a causal relationship between the stages of drug use.  In her words, “although the data 
show a clear sequence in drug use, a particular drug does not invariably lead to other 
drugs higher up the sequence” (p. 914).  Second, at no point did Kandel use the term 
‘gateway’ in the article.  As far as we have been able to ascertain, the notion of the 
‘gateway drug’ first appeared in Robert DuPont’s 1984 book Gateway Drugs: a Guide for 
the Family, a self-help manual aimed at parents.  However, some observers, including 
DuPont himself, indicate that the term was in use from the late 1970s (DuPont, Jaffe & 
Kleber, 1990; see also Zinberg, 1986-1987; Kandel, 1989).  Therefore, it is likely that the 
book merely instantiated an idea in wider circulation in drug control discourse and policy.  
One fact that supports this interpretation is that DuPont was the Director of the National 
Institute on Drug Abuse and the White House Drug Czar for much of the 1970s.  
 
As its title suggests, Gateway Drugs: a Guide for the Family presented gateway drugs as 
matters of fact that existed ‘out there’ in the world and whose major appeal lay in their 
seeming innocuousness, which served to ensnare unsuspecting young people (whom he 
deemed as being uniquely vulnerable to drug use/abuse).  The political utility of the 
concept must have been readily apparent to DuPont.  With a foreword by Ann Landers, 
and published as Nancy Reagan’s “Just Say No” campaign was building momentum, the 
book emphasized the “unique dangers” of “safe-seeming drugs” (p. 18), although 
cocaine and amphetamines were included along with alcohol and marijuana as gateway 
drugs.  While acknowledging the multi-causal nature of the “drug epidemic”, DuPont 
simultaneously highlighted the role of intoxication in causing physically-based 
dependence and ‘harder’ drug use.  DuPont’s underlying emphasis on causal 
biochemical mechanisms was evident in an interview about the book published in the 
Washington Post in 1985, where he warned that: “there’s no telling when the ‘addiction 
switch’ will turn on” (Weber, 1985).   
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All this would suggest that what is today labeled the ‘gateway theory’ represents the 
convergence of a distinct series of accounts, from lay models of drug use (the notion of 
the ‘stepping stone’), academic theories (Kandel’s ‘stages of progression’ model) and 
political constructs (DuPont’s ‘gateway drugs’).  In part, its success rests on its 
compatibility with popular views of deviance, in which escalation is a common theme.  
Drug use fits particularly well with ideas of escalation from the seemingly innocuous to 
the profoundly destructive because drugs are viewed as causal agents in a wide range 
of “calamities and failures of responsibility”, including violence, crime, school failure, 
family conflict and illness (Room, 2005, p. 149).  In addition, drug use is inevitably linked 
with addiction, understood as an inexorable decline from normality to ‘rock bottom’ 
(Keane, 2002).  In this cultural and discursive context, the gateway concept makes 
sense as a description and prediction of problematic behavior.  
 
Academic and policy literature on the gateway theory 
Interest in the idea of the ‘gateway theory’ or ‘gateway drugs’ has flourished over the 
past three decades amongst researchers, clinicians and policy makers.  Although it is 
beyond the scope of this paper to attempt a detailed analysis of the concept in the 
academic and policy literature, in an attempt to identify broad trends, we conducted 
Google Scholar searches of both terms in May 2014, limiting ourselves to documents 
published between 1975 and 2000, which arguably represents the concept’s formative 
period.  Google Scholar has the advantage of capturing a variety of different kinds of 
sources, from academic articles and books to ‘grey’ literature, and the list of citations it 
generates includes fragments of text where the search term is being used.  After 
removing irrelevant citations (e.g. ones on the gateway theory of pain) and those not in 
English, approximately 700 citations remained.  These citations form the basis of the 
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discussion that follows—although we examined the original source material in instances 
where it was unclear how the concept was being used in the textual fragment captured 
by Google Scholar. 
 
Our analysis suggests that the notion of ‘gateway drugs’ has generally resisted 
becoming a fact in Fleck (1979) or Latour’s (1987) sense, where concepts are invoked 
without any trace of ownership, construction, or time and place, as if it “could have been 
known for centuries or handed down by God Himself together with the Ten 
Commandments” (Latour, 1987, p. 23).  Although it was not uncommon to see the term 
employed in this fashion, in 75 percent of the citations it was marked in some way.  
Beyond the many instances where it was explicitly treated as a “theory” or “hypothesis”, 
it was often placed in scare quotes, and generally preceded by disclaimers such as “so-
called”, “considered” or “supposed”.   
 
Importantly, while the reality of gateway drugs is commonly treated as questionable, the 
existence of a named gateway theory (as with the stepping stone theory before it) is not.  
Yet, as we have shown, no such named theory was initially posited.  It is therefore clear 
that subsequent scholars writing on the topic actively produced the notion of a ‘gateway 
theory’ to describe a distinct series of ideas about progression in drug use.  For example, 
in a paper on adolescent drug use published following DuPont’s book, Oetting and 
Beauvais (1986) discussed a cluster of “gateway theories”, noting that numerous 
scientists had observed:  
…a remarkably orderly progression from one drug to another as young people 
get more and more heavily involved with drugs.  This observation has been 
variously labeled the gateway (DuPont, 1984), stepping stone (O’Connel & 
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Clayton, 1982), and precursors (Kandel, Kessler, & Margulies, 1978) hypothesis 
(pp. 17-18, emphasis and citations in original).   
Although this statement acknowledged that these were distinct accounts and source 
material was provided for each one, it simultaneously elided their differences through the 
framing of these observations as a singular ‘hypothesis’.  Similarly, in an article on 
gender and teenage smoking, Gritz (1986) noted that:   
The gateway theory of substance use predicts the order in which licit and illicit 
drugs are introduced, and analyses have been performed on continuation and 
discontinuation patterns (Jessor and Jessor 1977; Kandel 1978; Kandel and 
Logan 1984; O’Malley et al. 1984) (p. 74, citations in original).  
 
As Latour (1987, p. 29) has shown in his work on fact-making, “the fate of what we say 
and make is in later users’ hands”.  Thus, facts are made in part out of what we do with 
prior statements: taking them up, rejecting them, reopening them, dropping them, 
making them more solid by grasping them without further discussion, or transforming 
them entirely.  Oetting and Beauvais (1986) and Gritz’s (1986) statements therefore 
show us a fact in the process of being made.  For example, although none of the articles 
cited in Gritz’s statement are about a gateway theory of substance use, through her 
“context of citation” (Latour, 1987, p. 35) she treats these references as developing a 
“gateway theory of substance use”.  Thus, the descriptive act is actually a productive 
one, serving to instantiate the notion of a gateway theory.  
 
Kandel herself actively contributed to the life of the theory, titling her 1992 co-authored 
paper “States of progression in drug involvement from adolescence to adulthood: 
Further evidence for the gateway theory” (Kandel, Yamaguchi & Chen, 1992).  
Subsequent accounts accepted these statements and they continued to be “eroded and 
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polished” over time (Latour, 1987, p. 42). And so it was that the gateway theory became 
“tacit knowledge” (Latour, 1987, p. 43): a fact whose existence was universally accepted 
and required no citation.  In consequence, for the most part it is treated as a timeless, 
placeless, ownerless concept whose meaning is both transparent and self-evident. 
 
Despite this assumption of transparency, given the different propositions that collectively 
made up the gateway theory, the concept means different things to different people.   It 
is no wonder that Hall and Lynskey (2005, p. 39) observe that,  
The gateway hypothesis has been one of the most controversial hypotheses in 
the epidemiology of drug use.  This has been in part because proponents and 
opponents of the hypothesis have not always been clear about what the 
hypothesis means and what policies it entails. 
Nevertheless, in general, the theory encompasses a set of related propositions.  
According to Kandel (2002, 2003), it involves two elements: 1) sequencing of initiation of 
use between drug classes, and 2) association in the use of drugs, such that use of a 
drug lower in the sequences increase the risk of using drugs higher up the chain.  
Kandel is careful not to argue for a causal relationship, noting that: “given the difficulties 
of establishing true causality in the social sciences, the term association rather than 
causation is emphasized” (Kandel, 2002, p. 4, emphasis in original).   
 
However, as Vanyukov and colleagues (2012) observe, while those endorsing the 
gateway theory (including Kandel herself) often avoid explicit assertions of causality, it is 
common to see implicit causal claims; thus, expressions like “leads to”, “progresses to”, 
“predicts”, “increases the risk of”, “stages of progression”, “a causal chain sequence” are 
common.  This “cavalier approach” towards association is a common feature of 
epidemiological studies (Davey-Smith and Phillips, 1992, p. 759).  However, even when 
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epidemiologists studying drug use refrain from drawing hasty conclusions about possible 
links between causes and effects, their findings are quickly put to political work.  To 
quote Peretti-Watel (2011, p. 61), “any figures published are liable to be held up as 
‘scientific’ and immediately reinterpreted in policy-making circles, not to mention the 
heavy implications often attached to them when they begin to circulate in the media”.   
 
Despite media and policy claims to the contrary, the exact nature—and implications—of 
the association are quite unclear.  For example, Hall and Lynskey (2005) suggest that 
there are three main types of explanation for the association between cannabis and 
other illicit drug use (arguably the most politicized ‘gateway’ relationship).  First, social 
environment explanations posit that cannabis users have more opportunity to use illicit 
drugs because they are supplied by the same black market, and because of shared peer 
networks they are more exposed to illicit drug use.  Second, other explanations focus on 
the individual characteristics of cannabis users, suggesting that there is something about 
users that makes them more likely to use illicit drugs.  In other words, there is a third 
variable (e.g. a genetic predisposition to risk taking or a shared problematic 
environment) which causes both cannabis and other illicit drug use.  Finally, 
biochemical/pharmacologic explanations suggest that cannabis use produces changes 
in the brain that sensitize users to the rewarding effects of other drugs. These 
explanations draw much of their impetus from experiments with rats suggesting that 
“marijuana manipulates the brain’s stress and reward systems in the same way as more 
potent drugs, to keep users coming back for more” (Wickelgren, 1997, p. 1967). 
 
The gateway theory and conceptions of ‘hard’ and ‘soft’ drugs 
Questions of causality aside, there is empirical support for a patterned sequence in drug 
use in western countries, although this pattern is certainly not universal (see Degenhardt 
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et al., 2010; Vanyukov et al., 2012).  However, what does this actually tell us about drug 
use beyond the fact that some users tend to experiment with different types of drugs?  In 
many respects, the gateway theory is a kind of epidemiological “black box” (Peretti-
Watel, 2011).  As Vanyukov et al. (2012, p. S5) observe,  
The ‘stages’ are defined in a circular manner: a stage is said to be reached when 
a certain drug(s) is used, but this drug is supposed to be used only upon 
reaching this stage.  In other words, the stage both is identified by the drug and 
identifies that drug.  In effect, the drug is identical to the stage…  There is no 
process or organismic characteristic, separate from drug use per se, which is 
presumed to cause or underlie the supposed developmental staging indicated by, 
and identical to, drug milestones.  
 
Although the defining characteristic of the gateway theory is a movement from ‘softer’ to 
‘harder’ drugs, closer examination reveals that these categories, while generally treated 
as self-evident, are curiously slippery.  In many contexts the distinction is treated as 
synonymous with the move from licit to illicit drugs—a view which underwrites Kandel’s 
stages model of drug use (see Figure 1).  Yet, ‘hardness’ seems to frequently be 
conflated with ‘intoxicating’, and ‘softness’ seems to be used as synonymous with readily 
available/accessible drugs (e.g., DuPont, 1984).  In other treatments, still, ‘hardness’ 
seems to relate to the idea of ‘addictiveness’ or alternatively hinges on the notion of a 
‘less dangerous’/‘more harmful’ binary (Shiner & Newburn, 1997; Hartney, 2012).  
Distinctions are also made between different routes of administration, with injected drugs 
being identified with ‘hardness’—both in drug policy (Fraser et al., 2004) and amongst 
drug users themselves (Peretti-Watel & Moatti, 2005).  Clearly, depending on the 
particular frame used, the actual drugs populating the stages in the progression from 
softer to harder drugs might look rather different. 
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Moreover, it is common to see these multiple and internally contradictory meanings 
invoked in a single given account.  Getting Tough on Gateway Drugs is a case in point, 
as DuPont (1984) seems to distinguish ‘soft’ and ‘hard’ drugs in at least distinct three 
ways in the book.  Thus, he initially differentiates such drugs based on “their most 
prominent effects on the brain or the central nervous system” (p. 9); however, later he 
seems to evoke a cultural model of “safe” and “scary” drugs based not on their 
pharmacological properties but popular perception.  In his words:  
Another key to understanding which drugs emerged as major drug problems 
during the last two decades is the image each drug had.  Drugs that were 
perceived as ‘safe’ and ‘fun’ shot ahead of drugs considered ‘dangerous’.  Thus, 
marijuana, cocaine, and—to a lesser extent—Quaaludes and stimulants like 
amphetamines shot far ahead of scarier drugs such as heroin, LSD, PCP, and 
even barbiturates (p. 18).   
Finally, he seems to differentiate addictive drugs from intoxicating ones, focusing on the 
latter as ‘gateways’.  It is for this reason that he downplays the role of tobacco as a 
gateway drug, because it does not produce intoxication (p. 32).   
 
All this would suggest that a kind of collapsing of socio-legal, cultural and 
pharmacological categories has happened in the notion of gateway drugs, without 
adequate recognition of this conflation.  The slipperiness of what constitutes a softer vs. 
harder drug also means that the theory has considerable utility in directing attention 
towards whichever drug happens to be the focus of political ire.  Indeed, as we have 
already seen, the origins of the ideas promulgated in the form of the ‘stepping stone 
theory’ and ‘gateway drugs’ were fundamentally political.  As Anthony (2012, p. S101) 
highlights, the origins of the gateway theory lie in “the imaginations of politicians and 
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policy makers”.  Drug control policy’s system of classifications relies on a vision of drugs 
as more or less harmful because of internal properties such as ‘abuse potential’.  Thus, 
one of the most important effects of these different iterations of the gateway theory is to 
produce and naturalize the identity of certain substances as ‘soft’ (i.e. less inherently 
harmful but dangerous because of their role in the path of drug use) and other 
substances as ‘hard’ (i.e. inherently harmful). 
 
The seductiveness of the ‘gateway’ trope: the media’s uptake of the concept 
As the preceding account makes clear, the notion of the ‘gateway drug’ was never a 
purely academic concept, but rather a hybrid of political, popular and academic 
accounts.   The media has therefore had an important role to play in disseminating and 
popularizing the term. A LexisNexis search of media references to “gateway AND drug” 
in October 2013 placed the first reference to the concept in a Washington Post article in 
1985 discussing DuPont’s book (Weber, 1985).  “Gateway drugs” were also mentioned 
in US newspaper articles in both 1986 and 1989 (Braham, 1986; Schissler, 1989), with 
alcohol, cigarettes and marijuana all singled out as “gateways” or “bridges” to drugs such 
as heroin and cocaine.   These accounts tended to highlight the biochemical properties 
of these drugs as explanations for their “gateway effects”.  For example, a 1989 New 
York Times article emphasized the ways in which alcohol “accustoms young people to 
the feelings of mood alteration, so they are often wide-eyed to try other drugs, a colorful 
assortment of pills, potions and powders” (Schissler, 1989).  In each instance, the 
existence of gateway drugs were taken as given, rather than presented as a hypothesis 
or theory.   
 
Although sporadic mentions occurred in the early 1990s, it wasn’t until 1994 that the 
term was referenced more frequently in print news, and from 1997 gateway drugs were 
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frequently discussed, with cigarettes and marijuana most commonly singled out as 
culprits and explanations tending towards the biochemical, an orientation that likely 
reflects the increasing prominence of neuroscientific research during “the decade of the 
brain” (see Keane, 1999).  Gateway drugs, the reader was often informed, “prime the 
brain” or create “neuro-chemical pathways” for addiction (e.g., Morgan, 1997; Dayton, 
1997).   The emphasis on cigarettes as a gateway drug in media reports seems to be 
partially an artifact of proposed changes in tobacco control legislation and the political 
utility of the concept in promoting them.  Thus, in 1996 when the Clinton administration 
took steps to assert FDA jurisdiction over tobacco, arguments about tobacco as a 
gateway drug were common (e.g. Fagan, 1996; Siemaszko, 1996; Sims & Brogan, 
1996).  For example, an article published in the Canadian national newspaper The 
Globe and Mail discussing the FDA regulation quoted an official stating that: “The 
gateway drug in all substance abuse is basically smoking” (Fagan, 1996).   
 
Nevertheless, in contrast to earlier references to the term, from the mid 1990s gateway 
drugs were often presented as contested substances, although this was more common 
in accounts of cannabis than tobacco (e.g. Massing, 1996; Brighton, 1997).   For 
example, a New York Times article published in 1996 stated that there was “Little 
evidence to support the claim that marijuana is a ‘gateway drug’” (Massing 1996).  In 
1997 a letter to the editor published in The Gazette argued that characterizations of pot 
as a gateway drug could also be made for cigarettes, coffee, sex, regular jogging, and “a 
great plateful of fries and gravy” (Korhonen, 1997).  Indeed, over time there has also 
been a broadening of the concept and the trope of the “gateway substance” now extends 
well beyond the realm of drugs into other ‘suspect’ practices—although such accounts 
are informed by ideas about addiction, compulsion and deviance.  Thus, conservative 
commentators characterize video games as a “gateway drug” to real-life violence (Wilkie 
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& Blumenthal, 2013).  Likewise, pornography is described as a “gateway drug” to 
promiscuity (sexandthestate.com, 2013) and conservative Christians now talk of 
“gateway sins”, defined as “an unhealthy habit that at first seems innocent, but its 
continuation may lead to the indulgence of other sins” (urbangospelmission.com, 2012).  
Indeed, today it appears that pretty much any activity seen to ‘encourage’ or ‘facilitate’ 
entrée to another activity (generally one deemed to be compulsive or socially 
undesirable) can be conceptualized through the metaphor of the gateway drug; for 
example, articles talk of LinkedIn as a “gateway drug” to social media (Rudin, 2012). 
 
Clearly, as an account of human behavior, there is a degree of seductiveness to the idea 
that exposure to a single substance will lead people inexorably down a path of vice they 
would not otherwise have succumbed to (whether it be addiction, promiscuity, violence, 
and so on).  For if the substance is the problem, the answer then becomes simple: limit 
exposure.  Although the breadth of the gateway trope would suggest a dampening of the 
meaning of the concept, its potency nevertheless comes in part from its veneer of 
scientific credibility.  This is particularly evident in the ways the concept has been re-
energized in the context of debates about e-cigarettes. 
 
The resurrection of the gateway theory in e-cigarettes 
Electronic cigarettes are a product launched in 2006 by a Chinese electronics company.  
While some models resemble cigarettes, they do not involve combustion but are battery-
powered devices that deliver nicotine via an inhaled mist.  Opinion on e-cigarettes has 
quickly polarized.  While some tobacco harm reduction advocates have embraced e-
cigarettes as a safer alternative to smoking cigarettes, for many working in the field of 
tobacco control they are merely the latest incarnation of the tobacco ‘menace’: an 
untested product with the potential to enslave ever-greater numbers of people—
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especially adolescents—to a dangerous addiction (see Bell & Keane, 2012).   As 
Borland (2011) observes,  
People who argue that research is needed first focus primarily on the risks—the 
lack of research on product safety and on the efficacy of e-cigarettes as 
cessation aids or as substitutes, and concern about them being a potential 
gateway to nicotine dependence for the young.  
 
Despite these concerns, evidence that e-cigarettes lead one inexorably down a path 
towards smoking is very limited.  One highly-publicized study by the Centers for Disease 
Control and Prevention (CDC) found that the percentage of US high school students 
who reported ever using an e-cigarette rose from 4.7 percent in 2011 to 10.0 percent in 
2012 and high school students using e-cigarettes within the past 30 days rose from 1.5 
percent to 2.8 percent and doubled among middle school students (Corey et al., 2013).  
Although only 9.3% of e-cigarette users had never reported smoking a cigarette (i.e. less 
than 1% of the total respondents), the report ends with an ominous warning about the 
“risk for nicotine addiction and initiation of the use of conventional cigarettes or other 
tobacco products”.  In a press release about the study, Tom Frieden, the CDC Director, 
stated: “Nicotine is a highly addictive drug.  Many teens who start with e-cigarettes may 
be condemned to struggling with a lifelong addiction to nicotine and conventional 
cigarettes" (CDC, 2013).  The press has been quick to take up the study’s findings, with 
headlines screaming: “E-cigarettes: healthy tool or gateway device?” (CNN, 2013) and 
“E-cigarettes: a gateway to nicotine addiction?” (The Week, 2013).   
 
This leap from e-cigarette usage—or even awareness—to full-blown cigarette usage is 
readily made in other empirical research.  For example, in a recent study of US 
adolescent males’ awareness of and willingness to try e-cigarettes, Pepper et al. (2013) 
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found that very few adolescents had used the devices (<1%) but 18% indicated their 
willingness to experiment with them.  They conclude: “Given that even experimentation 
with e-cigarettes could lead to nicotine dependence and subsequent use of other 
tobacco products, regulatory and behavioral interventions are needed to prevent 
‘gateway’ use by adolescent nonsmokers” (p. 144).  A similar sort of logic is evident in a 
recent study of e-cigarette awareness and usage in South Korea (Lee et al., 2013).  In a 
survey of 75,643 students, the researchers found that 9.4% of students had ever used 
an e-cigarette, although the vast majority of these students also smoked cigarettes; only 
1.4% of students who had never smoked had used an e-cigarette.  Yet, based on this 
finding the authors conclude that: “e-cigarettes represent a new pathway for young 
people to become addicted to nicotine” (p. 4).   
 
Likewise, a recent systematic review of empirical research (Pepper & Brewer, 2013) 
discusses two studies in the context of “gateway use”.  Outlining the findings of a study 
of 179 e-cigarette users in Poland (Goniewicz et al., 2013), the reviewers note that 25 
participants reported that they were non-smokers when they began using e-cigarettes 
and 5 of these people currently reported smoking cigarettes.  They then describe the 
findings of a focus group study on young adults’ perceptions of smokeless tobacco and 
e-cigarettes (Choi et al., 2012), noting that the participants believed that these might 
appeal to non-smokers and lead them to becoming smokers.  Based on these studies, 
the reviewers highlight the existence of specific “vulnerable populations”, including “non-
smokers who could begin smoking as a result of developing nicotine addiction from 
ENDS [electronic nicotine delivery system] use” (p. 7).  However, the authors of the 
Polish study explicitly state that their survey “did not ask participants who reported no 
smoking at the time of starting the e-cigarette use about their smoking history.  It is likely 
that most or all of these respondents were smokers who were in the process of trying to 
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quit” (Goniewicz et al., 2013, 138).  Moreover, the focus group study (Choi et al., 2012) 
did not focus on actual e-cigarette usage but young adults’ perceptions of the products.  
Although no available studies examine patterns of e-cigarette and cigarette usage in a 
longitudinal fashion, virtually all assume the following inviolable chain reaction: 
awareness of e-cigarettes  experimentation with e-cigarettes  nicotine dependence 
 smoking.   
 
These concerns about the “gateway potential” of e-cigarettes pervade discussions of e-
cigarettes (see Etter & Bullen, 2011; Etter et al., 2011; Limb, 2013).   Although such 
concerns are most commonly expressed through the metaphor of the gateway drug, a 
related concern is that they will act as a “starter product” for combustible cigarettes (e.g. 
Pearson et al., 2012; Henningfield & Zaatari, 2010).  For example, Henningfield and 
Zaatari (2010, p. 89) state that: “ENDS [electronic nicotine delivery systems] that deliver 
very low levels of nicotine may pose effective starter products for non-tobacco users.  
Self-administering nicotine by puffing on ENDS could initiate a nicotine graduation 
process”.  The underlying concern in both instances is that non-smokers may use e-
cigarettes, become ‘hooked’ on nicotine and then turn to ‘real’ cigarettes to feed their 
addiction.  Interestingly, in many of these accounts, the emphasis on adolescent usage 
so integral to the initial conception of the gateway theory seems to have disappeared 
entirely, with e-cigarette users of any age deemed to be at risk of progression to full-
blown cigarette usage. 
 
Moreover, unlike the notion of sequenced pattern of drug use from licit to illicit drugs, the 
‘gateway’ is invoked here quite explicitly as a predictive model rather than an empirically-
driven one.  In other words, it entails a prediction of what will happen, rather than an 
explanation of a documented pattern of drug use.  Yet, the term is treated as if it speaks 
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to an empirical truth regarding the future of the e-cigarette user, one that policy makers 
have a responsibility to pre-empt via regulations to restrict the promotion and sale of e-
cigarettes.  
 
Nicotine and reconceptualizations of ‘hardness’ 
Another notable difference between invocations of the ‘gateway’ in the context of e-
cigarettes is the general absence of any reference to the concept’s initial orientation 
towards illicit drugs, where gateway drugs induce a continuous movement towards 
‘harder’ drugs (however that be defined).  Only rarely is the specter of escalating drug 
abuse invoked—and such speculation is limited to media reports.  For example, a recent 
NBC news article on e-cigarettes discusses a “life-long marijuana user” who uses his e-
cigarette to vape marijuana in public and concludes with a warning from New York State 
Assemblywoman Linda Rosenthal: “Once you try electronic cigarettes, you can become 
hooked to them, move on to cigarettes and then move on to other drugs” (Givens & 
Cheng, 2013, emphasis added).  Nevertheless, for public health and tobacco control 
advocates, the outcome that has everyone concerned is "a lifelong addiction to nicotine 
and conventional cigarettes" (CDC, 2013).  Here, cigarettes—initially perceived as a 
‘soft’ gateway to ‘harder’ drugs—have become the incontrovertibly harmful outcome that 
renders the earlier practice risky.    
 
In some respects, the debates about e-cigarettes are indicative of an underlying 
transformation in the notion of ‘hardness’, wherein nicotine has been repositioned as a 
stigmatized and socially unacceptable ‘hard’ drug, at least when contained in cigarettes.  
This is symptomatic of a larger revaluation of nicotine in the 1990s and its discursive 
shift in status from a ‘habituating’ drug to an ‘addictive’ one (see Luik, 1996; Bell & 
Keane, 2012). The notion of the ‘social smoker’ has been discredited as anything except 
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a transitional phenomenon in mainstream tobacco control (McCullough, 2011) and 
teenagers are warned that even smoking a few cigarettes can produce nicotine 
dependence (DiFranza et al., 2002).  This revaluation of nicotine has meant that its 
status as a ‘softer’ drug than cannabis in academic and policy circles—and, increasingly, 
the public imagination as well—is certainly up for debate, and researchers have now 
begun to talk of marijuana as a “reverse gateway” to cigarettes (e.g., Humfleet & Haas, 
2004; Patton et al., 2005; Viveros et al., 2006).   
 
Yet, although the invocation of the ‘gateway’ has been particularly frenzied in the context 
of media and policy discussions of e-cigarettes, we want to emphasize that this idea of 
nicotine as a gateway to smoking is not especially new.  In many respects, the current 
concerns about the gateway potential of e-cigarettes closely echo the longstanding 
debates about the role of smokeless tobacco in facilitating the uptake of smoking, a 
question which has formed the focus of no small amount of research (e.g., Haddock et 
al., 2001; Kozlowski et al., 2003; Tomar, 2003; Melikian & Hoffmann, 2009; Timberlake, 
Huh & Lakon, 2009).  Moreover, the dividing lines are largely unchanged, with 
proponents of tobacco harm reduction suggesting that these substances will reduce the 
toll exacted by smoking by encouraging users to switch to less hazardous forms of 
nicotine and opponents arguing that they will ultimately spawn more smokers.  
 
Interestingly, such concerns were also evident in earlier debates about nicotine 
replacement therapy (NRT) products, despite their medicinal status.  Thus, when 
Nicorettes were first introduced in the US in 1984, the FDA mandated that they could 
only be purchased by prescription, which was also the case for the nicotine patches 
introduced between 1991-1992.  By limiting access in this way, the explicit goal was to 
minimize the potential for “abuse” of these products amongst certain populations and to 
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ensure that smokers did not engage in “improper use” (Shiffman et al., 1997, p. 306).  
Concerns about the potential for youth uptake were a particularly prominent feature of 
the 1996 FDA hearings to make various NRT products (gum and patches) available for 
over-the-counter purchase.  The assumption was that open access to NRT would 
encourage teenagers to (ab)use the product (Shiffman et al., 1997; Shiffman & 
Sweeney, 2008).  Underlying such concerns about youth uptake was the assumption 
that NRT would potentially act as a ‘gateway’ to smoking (see Klesges et al., 2003; 
Adelman, 2004; Hyland et al., 2006).  
 
In these accounts, nicotine is revealed not as a stable substance but as one whose 
effects vary based on the specific networks in which it is embedded.  As Keane (2013, p. 
190) has previously argued:  
The categories of good and bad nicotine are precarious and contingent because 
of their reliance on the assemblage of elements such as drug effects, 
technological and clinical innovations, habits of tobacco consumption, regulatory 
frameworks and the interests of both tobacco and pharmaceutical companies in 
the smoking cessation/smoking reduction market. 
The nicotine in NRT products is ‘good’ because it weans smokers off the ‘bad’ nicotine in 
cigarettes and ideally nicotine itself (although it becomes ‘bad’ if smokers merely shift 
their nicotine addiction from cigarettes to Nicorettes).  On the other hand, the nicotine in 
e-cigarettes is ‘bad’ because it facilitates addiction to nicotine, which, in turn, drives the 
user to seek it in ‘harder’ or more dangerous forms.  And the nicotine in cigarettes is 
‘bad’ because it keeps the smoker using cigarettes.  Thus, in relation to e-cigarettes and 
smoking, the invocation of the ’gateway’ is a critical means of establishing the potential 
risks and dangers of both forms of nicotine use.  
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Conclusion 
Although the concept of the gateway theory is often treated as a straightforward 
scientific theory, its emergence is rather more complicated.  In effect, it is a hybrid of 
popular, academic and media accounts—a construct retroactively assembled rather than 
one initially articulated as a coherent theory.  We have argued that what the gateway 
theory is and what it means is neither fixed nor stable.  However, rather than detracting 
from its utility, this instability has been central to the continued productivity of the 
concept and its capacity to promote certain understandings of new forms of drug use 
structured around notions of harm, especially to young people.  By producing a simple 
narrative of escalating drug use, the gateway theory allows for quite different and 
specific processes (biological, legal, social and cultural) to be collapsed into a unified 
discourse of risk and harm. 
 
These processes crystallize clearly in recent debates about e-cigarettes, where the 
gateway theory has been taken up in quite distinctive ways.  Treated as a predictive 
rather than a descriptive model, concerns center on e-cigarettes as a ‘gateway’ or starter 
product for combustible cigarettes.  Most intriguing about the deployment of the concept 
in this context is that the ‘gateway’ in question is from nicotine to nicotine.  In this 
framing, nicotine is constituted as simultaneously ‘soft’ and ‘hard’—as both relatively 
innocuous and incontrovertibly harmful.  We have suggested that this path demonstrates 
and reproduces the changed status of smoking from its earlier identity as a precursor of 
harmful drug use to a form of harmful drug use in itself.  It also reveals the complexity of 
nicotine as an addictive substance which has been conceptually separated from the 
most prominent harms of smoking, but which is always seen to potentially spawn itself in 
new and more dangerous forms. 
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